Skip to content

The Factorial Structure of the Anhedonia List and its mediating role between Mindfulness and both Anxiety and Depression among University Students

Ahmed Mohamed Gadelrab Abouzaid, Heba Gaber Abdelhamid

Sohag University International Journal of Educational Research (SUIJER) /Sohag University International Journal of Educational Research July 1, 2023 DOI: 10.21608/suijer.2023.305894 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional psychometric and mediation study Peer reviewed
Sample size 740
Population University students from Sohag University, Egypt (first sample: 250; second sample: 490)
Measures Beck Scales for Depression and Anxiety, Mindfulness Scale, Short Social and Physical Anhedonia Scales, Anhedonia List (AL)
Topics Anxiety Depression Meditation
Key findings Anhedonia was found to be a multidimensional construct with four dimensions (cognitive, emotional, social, physical), each with three levels (desire, effort, experience). Anhedonia contributed to anxiety (64.6%) and depression (71.7%), and mindfulness contributed to anxiety (42.1%) and depression (47.3%). Anhedonia mediated the relationship between mindfulness and both anxiety and depression. The authors propose a new therapeutic approach, "Mindfulness Based Anhedonia Reduction (MBAR) Therapy."

Abstract

The current research aimed at identifying the factorial structure of the Anhedonia List (AL) and its mediating role between mindfulness and both anxiety and depression among university students. The first sample consisted of (250) students, males (n = 90) and females (n = 160), with (M=19.78, SD=2.95 years), from Sohag University students to calculate the factorial structure of the Anhedonia List (AL). The second sample consisted of 490 students Males (n=110) and females (n=380), average age (M= 20,21, SD=2,97), from Sohag University students to calculate the mediating role of anhedonia between mindfulness and symptoms of anxiety and depression. (Second search). The Beck Scales for Depression and Anxiety, the Mindfulness Scale, the Short Social and Physical Anhedonia Scales were used. For the purpose of the current research, an Anhedonia List (AL) was developed and tested for Validity and reliability. Using exploratory and confirmatory (χ2 / df= 1.625, RMSEA= 0.050, RMR= 0.032, IFI- 0.8, CFI= 0.8, TLI=0.8) factor analysis, it was found that anhedonia is a multi-dimensional construct with four dimensions: cognitive, emotional, social and physical. Each dimension has three levels: desire, effort, and experience. Regression Analysis revealed that anhedonia contributes to both anxiety (64.6%) and depression (71.7%), and mindfulness contributes to both anxiety (42.1%) and depression (47.3%). It was also found - through a structural model - that anhedonia plays a mediating role between mindfulness and both anxiety and depression among university students. It was recommended that further research be conducted to verify the psychometric properties of the list of anhedonia on other samples and environments, and to validate the current structural model on other disorders. Based on the results of the current research, a new therapeutic approach was proposed under the name "Mindfulness Based Anhedonia Reduction (MBAR) Therapy" to treat or reduce anxiety and depression disorders.

Comparable studies

Other cross-sectional and survey studies on anxiety, most cited first.

Study Year Design Participants
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. International sample of people who reported having used a psychedelic 2020 Cross-sectional survey n = 985
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin 2016 Questionnaire development and validation
Psychedelics and Mental Health: A Population Study Adult population in the United States 2013 Cross-sectional survey n = 130,152
Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users Ecstasy users who participated in a WWW study of recreational drug use 2002 Cross-sectional survey n = 282
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362

Citations in the library

Explore topics